THIRD ROCK VENTURES LP

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$86.84M

Insider Activity of THIRD ROCK VENTURES LP

The largest sale of all time was on 2017-03-23 and amounted to 2000000 shares of CytomX Therapeutics, Inc. for $34M.

Biography of THIRD ROCK VENTURES LP

No biography is available at this moment.

2017-03-27SaleCytomX Therapeutics, Inc.
CTMX
10 percent owner
1.3M
3.5363%
$18.00$23.4M-1.66%
2017-03-23SaleCytomX Therapeutics, Inc.
CTMX
10 percent owner
2M
5.3417%
$17.00$34M+2.01%
2014-09-12Salebluebird bio, Inc.
BLUE
10 percent owner
76,000
0.268%
$36.59$2.78M+220.38%
2014-09-11Salebluebird bio, Inc.
BLUE
10 percent owner
174,000
0.6192%
$36.52$6.35M+222.38%
2014-01-21Salebluebird bio, Inc.
BLUE
10 percent owner
250,000
1.0305%
$23.91$5.98M+42.94%
2014-01-17Salebluebird bio, Inc.
BLUE
10 percent owner
14,000
0.0586%
$23.96$335,440+44.47%
2014-01-16Salebluebird bio, Inc.
BLUE
10 percent owner
33,000
0.1368%
$24.02$792,660+42.62%
2014-01-15Salebluebird bio, Inc.
BLUE
10 percent owner
260,000
1.0571%
$22.14$5.76M+51.31%
2014-01-14Salebluebird bio, Inc.
BLUE
10 percent owner
270,000
1.111%
$21.91$5.92M+54.35%
2014-01-13Salebluebird bio, Inc.
BLUE
10 percent owner
45,000
0.1876%
$21.80$981,000+57.07%
2014-01-10Salebluebird bio, Inc.
BLUE
10 percent owner
25,000
0.1044%
$21.98$549,500+55.94%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.